The new genetics of schizophrenia

Psychiatric Clinics of North America

Volumn 26, Issue 1, 2003, Pages 41-63

  McDonald, Colm ^a   Murphy, Kieran C ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; CILIARY NEUROTROPHIC FACTOR; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2D; CYTOCHROME P450 3A4; DNA; GROWTH FACTOR; HLA ANTIGEN; NEUROTROPHIN 3; NOTCH RECEPTOR; SEROTONIN 2A RECEPTOR;

ADOPTION; BLOOD GROUP ABO SYSTEM; CHROMOSOME 22Q; CHROMOSOME ABERRATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DISEASE TRANSMISSION; DIZYGOTIC TWINS; DNA MICROARRAY; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; FAMILY STUDY; GENE FREQUENCY; GENE MAPPING; GENETIC COUNSELING; GENETIC EPIDEMIOLOGY; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HUMAN; MENTAL DISEASE; META ANALYSIS; MONOZYGOTIC TWINS; PHENOTYPE; PRIORITY JOURNAL; PSYCHOSIS; RECEPTOR GENE; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; VELOCARDIOFACIAL SYNDROME;

ADOPTION; CHROMOSOMES, HUMAN, PAIR 22; GENE DELETION; GENETIC COUNSELING; HUMANS; LINKAGE (GENETICS); PHENOTYPE; RISK FACTORS; SCHIZOPHRENIA; TWIN STUDIES;

EID: 0037350962     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0193-953X(02)00030-8     Document Type: Review

References (128)

1. Sherrington R, Brynjolfsson J, Petursson H, et al. Localization of a susceptibility locus for schizophrenia on chromosome 5. Nature 1988;336:164-7.
2. Gottesman II. Schizophrenia genesis: the origins of madness. New York: H Freeman & Co; 1991.
3. Essen-Moller E. The calculation of the morbid risk in parents of index cases as applied to a family sample of schizophrenics. Acta Genet 1955;5:334-42.
4. Coryell W, Zimmerman M. The heritability of schizophrenia and schizoaffective disorder: a family study. Arch Gen Psychiatry 1988;45:323-7.
5. Gershon ES, DeLisi LE, Hamovit J, et al. A controlled family study of chronic psychoses: schizophrenia and schizoaffective disorder. Arch Gen Psychiatry 1988;45:328-36.
6. Kendler KS, McGuire M, Gruenberg AM, et al. The Roscommon Family Study: I. methods, diagnosis of probands, and risk of schizophrenia in relatives. Arch Gen Psychiatry 1993;50:527-40.
7. Maier W, Lichtermann D, Minges J, et al. Continuity and discontinuity of affective disorders and schizophrenia: results of a controlled family study. Arch Gen Psychiatry 1993;50:871-83.
8. Parnas J, Cannon TD, Jacobsen B, et al. Lifetime DSM-III-R diagnostic outcomes in the offspring of schizophrenic mothers: results from the Copenhagen High-Risk Study. Arch Gen Psychiatry 1993;50:707-14.
9. Kendler KS. Overview: a current perspective on twin studies of schizophrenia. Am J Psychiatry 1983;140:1413-25.
10. McGuffin P, Farmer AE, Gottesman II, et al. Twin concordance for operationally defined schizophrenia: confirmation of familiality and heritability. Arch Gen Psychiatry 1984;41:541-5.
11. Farmer AE, McGuffin P, Gottesman II. Twin concordance for DSM-III schizophrenia: scrutinizing the validity of the definition. Arch Gen Psychiatry 1987;44:634-41.
12. Onstad S, Skre I, Torgersen S, et al. Twin concordance for DSM-III-R schizophrenia. Acta Psychiatr Scand 1991;83:395-401.
13. Gottesman II, Bertelsen A. Confirming unexpressed genotypes for schizophrenia: risks in the offspring of Fischer's Danish identical and fraternal discordant twins. Arch Gen Psychiatry 1989;46:867-72.
14. Cardno AG, Marshall EJ, Coid B, et al. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry 1999;56:162-8.
15. McGuffin P, Asherson P, Owen M, et al. The strength of the genetic effect: is there room for an environmental influence in the aetiology of schizophrenia? Br J Psychiatry 1994;164:593-9.
16. Cannon TD, Kaprio J, Lonnqvist J, et al. The genetic epidemiology of schizophrenia in a Finnish twin cohort: a population-based modeling study. Arch Gen Psychiatry 1998;55:67-74.
17. Heston LL. Psychiatric disorders in foster home reared children of schizophrenic mothers. Br J Psychiatry 1966;112:819-25.
18. Rosenthal D, Wender PH, Kety SS, et al. Schizophrenics' offspring reared in adoptive homes. In: Rosenthal D, Kety SS, editors. The transmission of schizophrenia. Oxford: Pergamon Press; 1968. p. 377-91.
19. Rosenthal D, Wender PH, Kety SS, et al. Parent-child relationships and psychopathological disorder in the child. Arch Gen Psychiatry 1975;32:466-76.
20. Wender PH, Rosenthal D, Kety SS, et al. Crossfostering: a research strategy for clarifying the role of genetic and experiential factors in the etiology of schizophrenia. Arch Gen Psychiatry 1974;30:121-8.
21. Kety SS. Mental illness in the biological and adoptive relatives of schizophrenic adoptees: findings relevant to genetic and environmental factors in etiology. Am J Psychiatry 1983;140:720-7.
22. Kety SS, Wender PH, Jacobsen B, et al. Mental illness in the biological and adoptive relatives of schizophrenic adoptees: replication of the Copenhagen study in the rest of Denmark. Arch Gen Psychiatry 1994;51:442-55.
23. Kety SS. Schizophrenic illness in the families of schizophrenic adoptees: findings from the Danish national sample. Schizophr Bull 1988;14:217-22.
24. Kendler KS, Gruenberg AM. An independent: analysis of the Danish adoption study of schizophrenia: VI. the relationship between psychiatric disorders as defined by DSM-III in the relatives and adoptees. Arch Gen Psychiatry 1984;41:555-64.
25. Kendler KS, Gruenberg AM, Kinney DK. Independent diagnoses of adoptees and relatives as defined by DSM-III in the provincial and national samples of the Danish Adoption Study of Schizophrenia. Arch Gen Psychiatry 1994;51:456-68.
26. Tienari P. Interaction between genetic vulnerability and family environment: the Finnish adoptive family study of schizophrenia. Acta Psychiatr Scand 1991;84:460-5.
27. Tienari P, Wynne LC, Moring J, et al. The Finnish adoptive family study of schizophrenia: implications for family research. Br J Psychiatry 1994;164:20-6.
28. O'Rourke DH, Gottesman II, Suarez BK. Refutation of the general single-locus model for the etiology of schizophrenia. Am J Hum Genet 1982;34:630-49.
29. McGue M, Gottesman II, Rao DC. Resolving genetic models for the transmission of schizophrenia. Genet Epidemiol 1985;2:99-110.
30. Risch N. Linkage strategies for genetically complex traits: I. multilocus models. Am J Hum Genet 1990;46:222-8.
31. Gottesman II, Shields J. A polygenic theory of schizophrenia. Proc Natl Acad Sci USA 1967;58:199-205.
32. Reich T, James JW, Morris CA. The use of multiple thresholds in determining the mode of transmission of semi-continuous traits. Ann Hum Genet 1972;36:163-84.
33. Risch N, Baron M. Segregation analysis of schizophrenia and related disorders. Am J Hum Genet 1984;36:1039-59.
34. Vogler GP, Gottesman II, McGue MK, et al. Mixed-model segregation analysis of schizophrenia in the Lindelius Swedish pedigrees. Behav Genet 1991;20:461-72.
35. Moldin SO, Gottesman II. At issue: genes, experience, and chance in schizophrenia - positioning for the 21st century. Schizophr Bull 1997;23:547-61.
36. Eisensmith RC, Martinez DR, Kuzmin AI, et al. Molecular basis of phenylketonuria and a correlation between genotype and phenotype in a heterogeneous southeastern US population. Pediatrics 1996;97:512-6.
37. Dryja TP, Berson EL. Retinitis pigmentosa and allied diseases: implications of genetic heterogeneity. Invest Ophthalmol Vis Sci 1995;36:1197-200.
38. Asherson P, Walsh C, Williams J, et al. Imprinting and anticipation: are they relevant to genetic studies of schizophrenia? Br J Psychiatry 1994;164:619-24.
39. Bassett AS, Honer WG. Evidence for anticipation in schizophrenia. Am J Hum Genet 1994;54:864-70.
40. Goate A, Chartier-Harlin MC, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-6.
41. Levy-Lahad E, Wasco W, Poorkaj P, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995;269:973-7.
42. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995;375:754-60.
43. Turner WJ. Genetic markers for schizotaxia. Biol Psychiatry 1979;14:177-206.
44. McGuffin P, Festenstein H, Murray R. A family study of HLA antigens and other genetic markers in schizophrenia. Psychol Med 1983;13:31-43.
45. Bassett AS, McGillivray BC, Jones BD, et al. Partial trisomy chromosome 5 cosegregating with schizophrenia. Lancet 1988;1:799-801.
46. McGuffin P, Sargeant M, Hetti G, et al. Exclusion of a schizophrenia susceptibility gene from the chromosome 5q11-q13 region: new data and a reanalysis of previous reports. Am J Hum Genet 1990;47:524-35.
47. Kalsi G, Mankoo B, Curtis D, et al. New DNA markers with increased informativeness show diminished support for a chromosome 5q11-13 schizophrenia susceptibility locus and exclude linkage in two new cohorts of British and Icelandic families. Ann Hum Genet 1999;63:235-47.
48. Moises HW, Yang L, Kristbjarnarson H, et al. An international two-stage genome-wide search for schizophrenia susceptibility genes. Nat Genet 1995;11:321-4.
49. Pulver AE, Lasseter VK, Kasch L, et al. Schizophrenia: a genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes. Am J Med Genet 1995;60:252-60.
50. Schwab SG, Albus M, Hallmayer J, et al. Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib-pair linkage analysis. Nat Genet 1995;11:325-7.
51. Wang S, Sun CE, Walczak CA, et al. Evidence for a susceptibility locus for schizophrenia on chromosome 6pter-p22. Nat Genet 1995;10:41-6.
52. Schizophrenia Linkage Collaborative Group for Chromosomes 3 a. Additional support for schizophrenia linkage on chromosomes 6 and 8: a multicenter study. Schizophrenia Linkage Collaborative Group for Chromosomes 3, 6 and 8. Am J Med Genet 1996;67:580-94.
53. Moises HW, Yang L, Li T, et al. Potential linkage disequilibrium between schizophrenia and locus D22S278 on the long arm of chromosome 22. Am J Med Genet 1995;60:465-7.
54. Gill M, Vallada H, Collier D, et al. A combined analysis of D22S278 marker alleles in affected sib-pairs: support for a susceptibility locus for schizophrenia at chromosome 22q12. Schizophrenia Collaborative Linkage Group (Chromosome 22). Am J Med Genet 1996;67:40-5.
55. Freedman R, Coon H, Myles-Worsley M, et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA 1997;94:587-92.
56. Kaufmann CA, Suarez B, Malaspina D, et al. NIMH Genetics Initiative Millenium Schizophrenia Consortium: linkage analysis of African-American pedigrees. Am J Med Genet 1998;81:282-9.
57. Liu CM, Hwu HG, Lin MW, et al. Suggestive evidence for linkage of schizophrenia to markers at chromosome 15q13-14 in Taiwanese families. Am J Med Genet 2001;105:658-61.
58. Lin MW, Curtis D, Williams N, et al. Suggestive evidence for linkage of schizophrenia to markers on chromosome 13q14.1-q32. Psychiatr Genet 1995;5:117-26.
59. Blouin JL, Dombroski BA, Nath SK, et al. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet 1998;20:70-3.
60. Straub RE, MacLean CJ, O'Neill FA, et al. Support for a possible schizophrenia vulnerability locus in region 5q22-31 in Irish families. Mol Psychiatry 1997;2:148-55.
61. Schwab SG, Eckstein GN, Hallmayer J, et al. Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility for schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis. Mol Psychiatry 1997;2:156-60.
62. Faraone SV, Matise T, Svrakic D, et al. Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium. Am J Med Genet 1998;81:290-5.
63. Schwab SG, Hallmayer J, Albus M, et al. Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by nonparametric linkage analysis. Am J Med Genet 1998;81:302-7.
64. Straub RE, MacLean CJ, Martin RB, et al. A schizophrenia locus may be located in region 10p15-p11. Am J Med Genet 1998;81:296-301.
65. Schwab SG, Hallmayer J, Lerer B, et al. Support for a chromosome 18p locus conferring susceptibility to functional psychoses in families with schizophrenia, by association and linkage analysis. Am J Hum Genet 1998;63:1139-52.
66. Shaw SH, Kelly M, Smith AB, et al. A genome-wide search for schizophrenia susceptibility genes. Am J Med Genet 1998;81:364-76.
67. Brzustowicz LM, Hodgkinson KA, Chow EW, et al. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science 2000;288:678-82.
68. Owen MJ, Holmans P, McGuffin P. Association studies in psychiatric genetics. Mol Psychiatry 1997;2:270-3.
69. Terwilliger JD, Ott J. A haplotype-based 'haplotype relative risk' approach to detecting allelic associations. Hum Hered 1992;42:337-46.
70. Schaid DJ, Sommer SS. Comparison of statistics for candidate-gene association studies using cases and parents. Am J Hum Genet 1994;55:402-9.
71. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-3.
72. McGuffin P, Sturt E. Genetic markers in schizophrenia. Hum Hered 1986;36:65-88.
73. Alexander RC, Coggiano M, Daniel DG, et al. HLA antigens in schizophrenia. Psychiatry Res 1990;31:221-33.
74. Moises HW, Gelernter J, Giuffra LA, et al. No linkage between D2 dopamine receptor gene region and schizophrenia. Arch Gen Psychiatry 1991;48:643-7.
75. Shaikh S, Gill M, Owen M, et al. Failure to find linkage between a functional polymorphism in the dopamine D4 receptor gene and schizophrenia. Am J Med Genet 1994;54:8-11.
76. Kalsi G, Sherrington R, Mankoo BS, et al. Linkage study of the D5 dopamine receptor gene (DRD5) in multiplex Icelandic and English schizophrenia pedigrees. Am J Psychiatry 1996;153:107-9.
77. Spurlock G. Williams J, McGuffin P, et al. European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms. Am J Med Genet 1998;81:24-8.
78. Crocq MA, Mant R, Asherson P, et al. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet 1992;29:858-60.
79. Asherson P, Mant R, Holmans P, et al. Linkage, association and mutational analysis of the dopamine D3 receptor gene in schizophrenia. Mol Psychiatry 1996;1:125-32.
80. Williams J, Spurlock G, Holmans P, et al. A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia. Mol Psychiatry 1998;3:141-9.
81. Williams J, Spurlock G, McGuffin P, et al. Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group. Lancet 1996;347:1294-6.
82. Spurlock G, Heils A, Holmans P, et al. A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter. Mol Psychiatry 1998;3:42-9.
83. Williams J, McGuffin P, Nothen M, et al. Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia. EMASS Collaborative Group. European Multicentre Association Study of Schizophrenia. Lancet 1997;349:1221.
84. Daniels JK, Williams NM, Williams J, et al. No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity. Am J Psychiatry 1996;153:268-70.
85. Chen CH, Lee YR, Wei FC, et al. Association study of NaIII and MspI genetic polymorphisms of catechol-O-methyltransferase gene and susceptibility to schizophrenia. Biol Psychiatry 1997;41:985-7.
86. Kunugi H, Vallada HP, Sham PC, et al. Catechol-O-methyltransferase polymorphisms and schizophrenia: a transmission disequilibrium study in multiply affected families. Psychiatr Genet 1997;7:97-101.
87. Li T, Ball D, Zhao J, et al. Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11. Mol Psychiatry 2000;5:77-84.
88. 108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001;98:6917-22.
89. Murray RM. Neurodevelopmental schizophrenia: the rediscovery of dementia praecox. Br J Psychiatry 1994;(Suppl 25):6-12.
90. Dawson E, Powell JF, Sham PC, et al. An association study of a neurotrophin-3 (NT-3) gene polymorphism with schizophrenia. Acta Psychiatr Scand 1995;92:425-8.
91. Gill M, Hawi Z, O'Neill FA, et al. Neurotrophin-3 gene polymorphisms and schizophrenia: no evidence for linkage or association. Psychiatr Genet 1996;6:183-6.
92. Hawi Z, Straub RE, O'Neill A, et al. No linkage or linkage disequilibrium between brain-derived neurotrophic factor (BDNF) dinucleotide repeat polymorphism and schizophrenia in Irish families. Psychiatry Res 1998;81:111-6.
93. Sakai T, Sasaki T, Tatsumi M, et al. Schizophrenia and the ciliary neurotrophic factor (CNTF) gene: no evidence for association. Psychiatry Res 1997;71:7-10.
94. De Luca A, Pasini A, Amati F, et al. Association study of a promoter polymorphism of UFDL gene with schizophrenia. Am J Med Genet 2001;105:529-33.
95. Wei J, Hemmings GP. The NOTCH4 locus is associated with susceptibility to schizo-phrenia. Nat Genet 2000;25:376-7.
96. Arranz M, Collier D, Sodhi M, et al. Association between clozapine response and allelic variation in 5-HT(2A) receptor gene. Lancet 1995;346:281-2.
97. Bassett AS. Chromosomal aberrations and schizophrenia: autosomes. Br J Psychiatry 1992;161:323-34.
98. Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardiofacial syndrome. Arch Gen Psychiatry 1999;56:940-5.
99. Karayiorgou M, Morris MA, Morrow B, et al. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci USA 1995;92:7612-6.
100. Bassett AS, Chow EWC, O'Neill S, et al. Genetic insights into the neurodevelopmental hypothesis of schizophrenia. Schizophr Bull 2001;27:417-30.
101. Murphy KC, Owen MJ. Velo-cardio-facial syndrome: a model for understanding the genetics and pathogenesis of schizophrenia. Br J Psychiatry 2001;179:397-402.
102. Gothelf D, Frisch A, Munitz H, et al. Velocardiofacial manifestations and microdeletions in schizophrenic inpatients. Am J Med Genet 1997;72:455-61.
103. Bassett AS, Hodgkinson K, Chow EW, et al. 22q11 deletion syndrome in adults with schizophrenia. Am J Med Genet 1998;81:328-37.
104. Myles-Worsley M, Coon H, McDowell J, et al. Linkage of a composite inhibitory phenotype to a chromosome 22q locus in eight Utah families. Am J Med Genet 1999;88:544-50.
105. O'Donovan MC, Guy C, Craddock N, et al. Expanded CAG repeats in schizophrenia and bipolar disorder. Nat Genet 1995;10:380-1.
106. Morris AG, Gaitonde E, McKenna PJ, et al. CAG repeat expansions and schizophrenia: association with disease in females and with early age-at-onset. Hum Mol Genet 1995;4:1957-61.
107. Breschel TS, McInnis MG, Margolis RL, et al. A novel, heritable, expanding CTG repeat in an intron of the SEF2-1 gene on chromosome 18q21.1. Hum Mol Genet 1997;6:1855-63.
108. Ikeuchi T, Sanpei K, Takano H, et al. A novel long and unstable CAG/CTG trinucleotide repeat on chromosome 17q. Genomics 1998;49:321-6.
109. Kendler KS, McGuire M, Gruenberg AM, et al. Outcome and family study of the subtypes of schizophrenia in the west of Ireland. Am J Psychiatry 1994;151:849-56.
110. Beckmann H, Franzek E, Stober G. Genetic heterogeneity in catatonic schizophrenia: a family study. Am J Med Genet 1996;67:289-300.
111. Berrettini WH. Are schizophrenic and bipolar disorders related? A review of family and molecular studies. Biol Psychiatry 2000;48:531-8.
112. Wickham H, Murray RM. Can biological markers identify endophenotypes predisposing to schizophrenia? Int Rev Psychiatry 1997;9:355-64.
113. Siegel C, Waldo M, Mizner G, et al. Deficits in sensory gating in schizophrenic patients and their relatives: evidence obtained with auditory evoked responses. Arch Gen Psychiatry 1984;41:607-12.
114. Blackwood DH, Muir WJ. Cognitive brain potentials and their application. Br J Psychiatry 1990;9(Suppl):96-101.
115. Holzman PS, Kringlen E, Matthysse S, et al. A single dominant gene can account for eye tracking dysfunctions and schizophrenia in offspring of discordant twins. Arch Gen Psychiatry 1988;45:641-7.
116. Crawford TJ, Sharma T, Puri BK, et al. Saccadic eye movements in families multiply affected with schizophrenia: the Maudsley Family Study. Am J Psychiatry 1998;155:1703-10.
117. Cannon TD, Zorrilla LE, Shtasel D, et al. Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers. Arch Gen Psychiatry 1994;51:651-61.
118. Sharma T, Lancaster E, Lee D, et al. Brain changes in schizophrenia: volumetric MRI study of families multiply affected with schizophrenia - the Maudsley Family Study 5. Br J Psychiatry 1998;173:132-8.
119. Wyatt RJ. Early intervention for schizophrenia: can the course of the illness be altered? Biol Psychiatry 1995;38:1-3.
120. McGuire PK, Jones P, Harvey I, et al. Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis. Schizophr Res 1995;15:277-81.
121. Levy-Mozziconacci A, Piquet C, Heurtevin PC, et al. Prenatal diagnosis of 22q11 microdeletion. Prenat Diagn 1997;17:1033-7.
122. Arranz MJ, Munro J, Birkett J, et al. Pharmacogenetic prediction of clozapine response. Lancet 2000;355:1615-6.
123. Wolf CR, Smith G, Smith RL. Science, medicine, and the future: pharmacogenetics. BMJ 2000;320:987-90.
124. Olesen OV, Thomsen K, Jensen PN, et al. Clozapine serum levels and side effects during steady state treatment of schizophrenic patients: a cross-sectional study. Psychopharmacology (Berl) 1995;117:371-8.
125. Aitchison KJ, Jann MW, Zhao JH, et al. Clozapine pharmacokinetics and pharmacodynamics studied with Cyp1A2- null mice. J Psychopharmacol 2000;14:353-9.
126. Roses AD. Pharmacogenetics and the practice of medicine. Nature 2000;405:857-65.
127. Hoh JJ, Ott J. Complex inheritance and localizing disease genes. Hum Hered 2000;50:85-9.
128. Rao DC, Province MA. The future of path analysis, segregation analysis, and combined models for genetic dissection of complex traits. Hum Hered 2000;50:34-42.